Teens Age 12-17 with Asthma

Trial Objective

Teen Asthma Investigational MedicationThe purpose of this study is to determine if an investigational medication, Fevipiprant, improves breathing in teens with uncontrolled asthma.

Study details:

  • 9 visits to National Jewish Health over a 5 month period
  • Investigational medicine is taken in addition to standard-of-care therapy and is in the form of a pill
  • Medical evaluations (including breathing tests and physical examinations) at no cose
  • Asthma education
  • Financial compensation for time and travel for qualified participants


This trial is active and currently recruiting.

Who Can Participate

Teens age 12-17 with a diagnosis of asthma for at least six months who are being treated with daily asthma medications may be eligible to participate.

Age: 12-17    Gender: Any Gender

Estimated Time Commitment

About 9 visits over approximately 19 weeks

Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Michael White

Michael White

D Sundstrom

Dee Sundstrom

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Novartis Pharmaceuticals Corporation

Request More Information